Sullivan Bruyette Speros & Blaney LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 15.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,476 shares of the healthcare conglomerate’s stock after purchasing an additional 464 shares during the period. Sullivan Bruyette Speros & Blaney LLC’s holdings in UnitedHealth Group were worth $645,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Blue Chip Partners Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter valued at $110,000. Patriot Financial Group Insurance Agency LLC lifted its holdings in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after purchasing an additional 603 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares in the last quarter. BDO Wealth Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at $121,000. Finally, Kings Point Capital Management lifted its holdings in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after purchasing an additional 150 shares in the last quarter. Institutional investors own 86.14% of the company’s stock.
UNH has been the subject of a number of research analyst reports. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein restated an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Deutsche Bank AG increased their target price on UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a report on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and an average target price of $216.65.
COPYRIGHT VIOLATION WARNING: This news story was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be accessed at https://www.com-unik.info/2017/11/03/unitedhealth-group-incorporated-unh-shares-bought-by-sullivan-bruyette-speros-blaney-llc.html.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $2.17 EPS.
In other news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now directly owns 24,630 shares in the company, valued at approximately $5,060,726.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares in the company, valued at $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold a total of 72,149 shares of company stock worth $14,212,342 over the last 90 days. 0.89% of the stock is owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.